336 related articles for article (PubMed ID: 23791247)
1. Nutraceuticals for older people: facts, fictions and gaps in knowledge.
González-Sarrías A; Larrosa M; García-Conesa MT; Tomás-Barberán FA; Espín JC
Maturitas; 2013 Aug; 75(4):313-34. PubMed ID: 23791247
[TBL] [Abstract][Full Text] [Related]
2. Nutraceuticals: facts and fiction.
Espín JC; García-Conesa MT; Tomás-Barberán FA
Phytochemistry; 2007; 68(22-24):2986-3008. PubMed ID: 17976666
[TBL] [Abstract][Full Text] [Related]
3. Nutraceuticals and botanicals: overview and perspectives.
Nicoletti M
Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():2-6. PubMed ID: 22360273
[TBL] [Abstract][Full Text] [Related]
4. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.
Gulati OP; Berry Ottaway P
Toxicology; 2006 Apr; 221(1):75-87. PubMed ID: 16487647
[TBL] [Abstract][Full Text] [Related]
5. Nutraceuticals and prevention of atherosclerosis: focus on omega-3 polyunsaturated fatty acids and Mediterranean diet polyphenols.
Massaro M; Scoditti E; Carluccio MA; De Caterina R
Cardiovasc Ther; 2010 Aug; 28(4):e13-9. PubMed ID: 20633019
[TBL] [Abstract][Full Text] [Related]
6. Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function.
Zuchi C; Ambrosio G; Lüscher TF; Landmesser U
Cardiovasc Ther; 2010 Aug; 28(4):187-201. PubMed ID: 20553294
[TBL] [Abstract][Full Text] [Related]
7. Nutraceuticals and atherosclerosis: human trials.
Badimon L; Vilahur G; Padro T
Cardiovasc Ther; 2010 Aug; 28(4):202-15. PubMed ID: 20633023
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.
Cicero AF; Ferroni A; Ertek S
Expert Opin Drug Saf; 2012 Sep; 11(5):753-66. PubMed ID: 22788832
[TBL] [Abstract][Full Text] [Related]
9. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
Coppens P; da Silva MF; Pettman S
Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies.
Jain S; Buttar HS; Chintameneni M; Kaur G
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):145-157. PubMed ID: 30109827
[TBL] [Abstract][Full Text] [Related]
11. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
13. Why the European Food Safety Authority was right to reject health claims for probiotics.
Katan MB
Benef Microbes; 2012 Jun; 3(2):85-9. PubMed ID: 22683835
[TBL] [Abstract][Full Text] [Related]
14. Health-beneficial nutraceuticals-myth or reality?
Sauer S; Plauth A
Appl Microbiol Biotechnol; 2017 Feb; 101(3):951-961. PubMed ID: 28070666
[TBL] [Abstract][Full Text] [Related]
15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
16. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
17. The EFSA health claims 'learning experience'.
Vero V; Gasbarrini A
Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():14-6. PubMed ID: 22087565
[TBL] [Abstract][Full Text] [Related]
18. Health foods and foods with health claims in Japan.
Ohama H; Ikeda H; Moriyama H
Toxicology; 2006 Apr; 221(1):95-111. PubMed ID: 16488527
[TBL] [Abstract][Full Text] [Related]
19. Medicinal halophytes: potent source of health promoting biomolecules with medical, nutraceutical and food applications.
Ksouri R; Ksouri WM; Jallali I; Debez A; Magné C; Hiroko I; Abdelly C
Crit Rev Biotechnol; 2012 Dec; 32(4):289-326. PubMed ID: 22129270
[TBL] [Abstract][Full Text] [Related]
20. Nutraceuticals in diabetes and metabolic syndrome.
Davì G; Santilli F; Patrono C
Cardiovasc Ther; 2010 Aug; 28(4):216-26. PubMed ID: 20633024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
